Nadia Rosenthal is an internationally recognised leader in molecular genetics, developmental biology and the role of growth factors, stem cells and immune responses in regenerative medicine. Her work has led to major discoveries in the past decade with significant therapeutic applications, and 200+ primary research articles and prominent reviews in high impact journals. She founded the Australian Regenerative Medicine Institute, and established EMBL Australia. She was awarded the Ferrari-Soave Prize, Doctors Honoris Causa from the Curie University, Paris and University of Amsterdam. She is an EMBO member, an Australia Fellow and a Fellow of the Academy of Medical Sciences, UK.